Francisco Manuel Nadal Nicolas-rekin lankidetzan egindako argitalpenak (20)

2019

  1. Melanopsin+RGCs are fully resistant to NMDA-Induced excitotoxicity

    International Journal of Molecular Sciences, Vol. 20, Núm. 12

  2. Topical bromfenac transiently delays axotomy-induced retinal ganglion cell loss

    Experimental Eye Research, Vol. 182, pp. 156-159

2016

  1. Ketorolac administration attenuates retinal ganglion cell death after axonal injury

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 3, pp. 1183-1192

  2. Melanopsin-containing or non-melanopsin-containing retinal ganglion cells response to acute ocular hypertension with or without brain-derived neurotrophic factor neuroprotection

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 15, pp. 6652-6661

  3. Topical treatment with bromfenac reduces retinal gliosis and inflammation after optic nerve crush

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 14, pp. 6098-6106